Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Total Liabilities: 2013-2022

Historic Total Liabilities for Avadel Pharmaceuticals (AVDL) over the last 7 years, with Sep 2022 value amounting to $158.2 million.

  • Avadel Pharmaceuticals' Total Liabilities fell 4.20% to $158.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $158.2 million, marking a year-over-year decrease of 4.20%. This contributed to the annual value of $169.0 million for FY2021, which is 13.16% up from last year.
  • As of Q3 2022, Avadel Pharmaceuticals' Total Liabilities stood at $158.2 million, which was down 1.90% from $161.3 million recorded in Q2 2022.
  • Avadel Pharmaceuticals' 5-year Total Liabilities high stood at $264.8 million for Q1 2018, and its period low was $149.4 million during Q4 2020.
  • Moreover, its 3-year median value for Total Liabilities was $161.3 million (2022), whereas its average is $161.9 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first spiked by 32.66% in 2018, then crashed by 30.82% in 2019.
  • Avadel Pharmaceuticals' Total Liabilities (Quarterly) stood at $187.5 million in 2018, then fell by 3.67% to $180.6 million in 2019, then declined by 17.31% to $149.4 million in 2020, then rose by 13.16% to $169.0 million in 2021, then dropped by 4.20% to $158.2 million in 2022.
  • Its Total Liabilities stands at $158.2 million for Q3 2022, versus $161.3 million for Q2 2022 and $165.9 million for Q1 2022.